XML 32 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes:
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Income Taxes
 
Income from continuing operations before taxes for the years ended December 31, 2015, 2014 and 2013 is as follows: 
 
 
2015
 
2014
 
2013
United States
 
$
74,288

 
$
33,508

 
$
48,964

Foreign
 
(4,589
)
 
6,284

 
3,750

 
 
$
69,699

 
$
39,792

 
$
52,714



The provision (benefit) for income taxes for the years ended December 31, 2015, 2014 and 2013 is as follows:
 
 
2015
 
2014
 
2013
Current:
 
 

 
 

 
 

Federal
 
$
18,601

 
$
13,860

 
$
14,575

State
 
745

 
(1,305
)
 
2,145

Foreign
 
1,426

 
2,100

 
(70
)
 
 
20,772

 
14,655

 
16,650

Deferred:
 
 

 
 

 
 

Federal
 
$
4,524

 
$
(2,325
)
 
$
164

State
 
(960
)
 
988

 
(996
)
Foreign
 
378

 
139

 
(3,522
)
 
 
3,942

 
(1,198
)
 
(4,354
)
 
 
$
24,714

 
$
13,457

 
$
12,296


 
Current income taxes payable were reduced from the amounts in the above table by $9.3 million, $5.7 million and $7.0 million in 2015, 2014 and 2013, respectively, equal to the direct tax benefit that we receive upon exercise of stock options by employees and directors. The benefit is allocated to stockholders’ equity. We have accrued for tax contingencies for potential tax assessments, and in 2015 we recognized a $1.8 million net decrease, most of which related to various federal and state tax reserves.
 
Reconciliations of the provision for income taxes at the statutory rate to our effective tax rate for the years ended December 31, 2015, 2014 and 2013 are as follows:
 
 
2015
 
2014
 
2013
 
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
Federal tax at the expected statutory rate
 
$
24,395

 
35.0
 %
 
$
13,927

 
35.0
 %
 
$
18,450

 
35.0
 %
State income tax, net of federal effect
 
2,661

 
3.9
 %
 
981

 
2.5
 %
 
1,126

 
2.1
 %
Tax credits
 
(5,861
)
 
(8.4
)%
 
(1,591
)
 
(4.0
)%
 
(1,974
)
 
(3.7
)%
Tax-exempt interest and dividends
 

 
 %
 
(3
)
 
 %
 

 
 %
Domestic production activities/other
 
107

 
0.1
 %
 
104

 
0.2
 %
 
(403
)
 
(0.8
)%
Foreign income tax
 
3,412

 
4.9
 %
 
39

 
0.1
 %
 
(4,903
)
 
(9.3
)%
 
 
$
24,714

 
35.5
 %
 
$
13,457

 
33.8
 %
 
$
12,296

 
23.3
 %

 
Tax credits in 2015, 2014 and 2013 consist principally of research and developmental tax credits.  The indirect effect of non-statutory stock options exercised on research and development tax credits and other tax credits were recorded as reductions of the effective tax provision.

The components of our deferred income tax provision for the years ended December 31, 2015, 2014 and 2013 are as follows: 
 
 
2015
 
2014
 
2013
Allowance for doubtful accounts
 
$

 
$
4

 
$
4

Inventory reserves
 
284

 
(488
)
 
341

Accruals
 
(2,977
)
 
(1,326
)
 
(470
)
State income taxes
 
502

 
(4
)
 
552

Acquired future tax deductions
 
3,139

 
96

 
40

Depreciation and amortization
 
1,080

 
(780
)
 
(3,850
)
Net operating loss
 
195

 
62

 

Tax credits
 
(635
)
 
1,238

 
(971
)
Valuation allowance
 
2,354

 

 

 
 
$
3,942

 
$
(1,198
)
 
$
(4,354
)
 
 
 
 
 
 
 


The components of our deferred income tax assets (liabilities) at December 31, 2015 and 2014 are as follows:

 
 
2015
 
2014
Deferred tax asset:
 
 

 
 

State income taxes
 
$
(1,647
)
 
$
(1,862
)
Foreign
 
3,881

 
$
1,905

Accruals/other
 
1,432

 
2,604

Depreciation and amortization
 
(11,735
)
 
(5,594
)
Acquired future tax deductions
 
5,778

 
639

Stock-based compensation
 
8,864

 
6,778

Foreign currency translation adjustments
 
5,360

 
2,680

Tax credits state
 
5,887

 
5,102

Inventory reserves
 
1,633

 
1,538

Allowance for doubtful accounts
 

 
151

Valuation allowance
 
(2,354
)
 

 
 
$
17,099

 
13,941

Deferred tax liability:
 
 

 
 

Foreign
 
$
1,372

 
$
1,376

 
 
$
1,372

 
$
1,376


 
Acquired future tax deductions are the tax benefits included in our consolidated income tax returns originating in Bio-Plexus, Inc., an entity purchased in 2002, prior to when we acquired the entity, and those originating from EXC Holding Corp. ("EXC") acquired in 2015. They consist of: (a) the net tax benefit of items expensed for financial statement purposes but capitalized and amortized for tax purposes, (b) the tax benefited portion of Bio-Plexus’s federal net operating loss ("NOL") carry-forward which will be realized in approximately equal amounts over the next 8 years, and (c) the tax benefited portion of EXC's NOL carryforward of $4.9 million is expected to be realized in approximately 6 years, and will expire in 18 years. Under Section 382 of the Internal Revenue Code, certain ownership changes limit the utilization of the NOL carry-forwards, and the amount of federal NOL carry-forwards recorded is the net federal benefit available.

A net change in the valuation allowance of $2.4 million was recorded against the deferred tax assets of our Slovakia subsidiary due to a change in realization as a result of the decision to close the manufacturing facility.
 
Foreign currency translation adjustments, and related tax effects, are an element of “other comprehensive income” and are not included in net income.

Our estimate of undistributed earnings of our foreign subsidiaries for which no federal or state liability has been recorded cumulatively was $17.8 million at December 31, 2015 and $14.5 million at December 31, 2014.  These undistributed earnings are considered to be indefinitely reinvested. However, if unanticipated distribution of those earnings were to occur in the form of dividends or otherwise, some portion of the distribution would be subject to both foreign withholding taxes and U.S. income taxes.  In the event that our position in this regard changes, determining the potential amount of unrecognized deferred federal and state income tax liability and foreign withholding taxes is not practicable because of the complexities associated with its hypothetical calculation. However, unrecognized foreign tax credits would be available to reduce some portion of the federal liability.

We are subject to taxation in the United States and various states and foreign jurisdictions. Our United States federal income tax returns for tax years 2012 and forward are subject to examination by the Internal Revenue Service. Our principal state income tax returns for tax years 2013 and forward are subject to examination by the state tax authorities. The total gross amount of unrecognized tax benefits as of December 31, 2015 was $1.8 million that, if recognized, would impact the effective tax rate.
 
The following table summarizes our cumulative gross unrecognized tax benefits for 2015, 2014 and 2013
 
 
2015
 
2014
 
2013
Beginning balance
 
$
4,115

 
$
5,544

 
$
4,236

Increases to prior year tax positions
 
25

 
217

 
391

Increases to current year tax positions
 
345

 
661

 
1,353

Decreases to prior year tax positions
 
(2,399
)
 

 

Decrease related to settlements
 
(314
)
 
(2,113
)
 

Decrease related to lapse of statute of limitations
 

 
(194
)
 
(436
)
Ending balance
 
$
1,772

 
$
4,115

 
$
5,544